Find out all the key statistics for Bristol-Myers Squibb Company (BMY), including valuation measures, fiscal year financial statistics, trading record, ...

Valuation Measures. Current Quarterly Annual. As of 11/29/2024. Market Cap. 120.11B. Enterprise Value. 163.41B. Trailing P/E. --. Forward P/E. 8.36. PEG Ratio ( ...

According to Wall Street analysts, the average 1-year price target for BMY is 58.46 USD with a low forecast of 33.43 USD and a high forecast of 76.65 USD.

Review the current valuation for Bristol-Myers Squibb Co (BMY:XMEX) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other ...

Bristol Myers Squibb · Share Price · Forbes Lists · Bristol Myers Squibb Financial Summary · Key Data · Valuation Measures · Profitability Metrics · Revenue and ...

Estimated DCF Value of one BMY stock is 69.04 USD. Compared to the current market price of 59.22 USD, the stock is Undervalued by 14%.

Find the latest Bristol-Myers Squibb Co (BMY | US1101221083USD) company operating performance and valuation plus latest price, trades, performance, company

Price-To-Sales vs Fair Ratio: BMY is good value based on its Price-To-Sales Ratio (2.5x) compared to the estimated Fair Price-To-Sales Ratio (6.6x).

Trefis Estimates Bristol-Myers Squibb Valuation At $63 Per Share · vs. Market Price Per Share of $59.24 (as of 11/29/2024). Implied Upside Potential: 6.3% ...